People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Biotechnology, Other Technology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Instylla, Inc. | — | Biotechnology | Series B | $85.5M | $100.2M | 2020 |
| Augmenix Inc | — | Biotechnology | Series A | $40.6M | $216.9M | 2011 |
| Innroad Inc | — | Other Technology | Series A | $13.4M | $27.7M | 2012 |
| Odyssey Health Inc. | — | Healthtech | Seed | $1.1M | $3.4M | 2025 |
Patrick Campbell at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Patrick Campbell on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| FARHAD KHOSRAVI | 2 | 14 |
| Tara Butler | 2 | 12 |
| Amarpreet Sawhney | 2 | 8 |
| Steven Cagnetta | 2 | 5 |
| Tasneem Dohadwala | 2 | 2 |
| Matthew Christensen | 1 | 8 |
| Henry Chen | 1 | 7 |
| Mark Volchek | 1 | 7 |
| Darshana Zaveri | 1 | 5 |
| Mark Schneider | 1 | 5 |
| Gary Goldberg | 1 | 5 |
| John M. May | 1 | 2 |
| Daniel Callahan | 1 | 2 |
| Sam Sezak | 1 | 2 |
| Shane Holdaway | 1 | 2 |
| John Pedersen | 1 | 1 |
| Neel Desai | 1 | 1 |
| Facundo Chamut | 1 | 1 |
| Luomeng Yu | 1 | 1 |
| Raymond Lareau | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.